MAIA Biotechnology Inc. (MAIA) — Financial Flexibility Index
MAIA Biotechnology Inc. (MAIA) has a Financial Flexibility Index of -0.70x as of March 2026. Free cash flow of $-5.31 Million (operating CF $-5.31 Million minus capex $0.00) represents -1% of total liabilities ($7.56 Million). Check tangible net worth ratio of MAIA Biotechnology Inc. to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
MAIA Biotechnology Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for MAIA Biotechnology Inc. across 7 annual periods. For the full cash flow conversion analysis, see MAIA operating cash flow.
Annual Financial Flexibility Index for MAIA Biotechnology Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for MAIA Biotechnology Inc.. Explore debt repayment capacity of MAIA Biotechnology Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.57x | $-18.84 Million | $-18.84 Million | $7.33 Million | ▼ -6.8% |
| 2024 | -2.41x | $-15.70 Million | $-15.70 Million | $6.52 Million | ▼ -30.6% |
| 2023 | -1.84x | $-13.07 Million | $-13.07 Million | $7.09 Million | ▲ +46.4% |
| 2022 | -3.44x | $-12.10 Million | $-12.10 Million | $3.51 Million | ▼ -79.2% |
| 2021 | -1.92x | $-4.12 Million | $-4.12 Million | $2.15 Million | ▼ -146.2% |
| 2020 | -0.78x | $-1.84 Million | $-1.84 Million | $2.36 Million | ▲ +79.6% |
| 2019 | -3.82x | $-1.57 Million | $-1.57 Million | $409.74K | — |